Latest Articles
Karyopharm endometrial cancer trial misses primary endpoint - Investing.com
Karyopharm endometrial cancer trial misses primary endpoint Investing.com
Published: July 30, 2026, 8:31 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - Karyopharm
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer Karyopharm
Published: July 30, 2026, 8:09 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - marketscreener.com
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer marketscreener.com
Published: July 30, 2026, 8:07 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - PR Newswire
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer PR Newswire
Published: July 30, 2026, 8:05 p.m.
Q&A: Are environmental chemicals and endometrial cancer linked? - Medical Xpress
Q&A: Are environmental chemicals and endometrial cancer linked? Medical Xpress
Published: July 30, 2026, 11:20 a.m.
Q&A: Are environmental chemicals and endometrial cancer linked? - medicalxpress.com
Q&A: Are environmental chemicals and endometrial cancer linked? medicalxpress.com
Published: July 30, 2026, 11:20 a.m.
Endometrial Cancer in 2026: A practical update for Irish clinicians - Irish Medical Times
Endometrial Cancer in 2026: A practical update for Irish clinicians Irish Medical Times
Published: July 30, 2026, 10:09 a.m.
Endometrial Cancer in 2026: A practical update for Irish clinicians - imt.ie
Endometrial Cancer in 2026: A practical update for Irish clinicians imt.ie
Published: July 30, 2026, 10:09 a.m.
A 3D PDMS Scaffold Microchip Platform for Non-Invasive Detection of Circulating Endometrial Cells: Revolutionizing Endometriosis Diagnosis.
To address the urgent need for non-invasive diagnosis of endometriosis, this study developed a novel microfluidic platform utilizing a three-dimensional (3D) polydimethylsiloxane scaffold microchip to efficiently capture circulating endometrial cells …
Published: July 30, 2026, midnight
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer - OncLive
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer OncLive
Published: July 29, 2026, 5:21 p.m.
Link copied to clipboard!